Indian Institute of Public Health Gandhinagar, Lekawada, Gandhinagar, India.
University of Canberra, Canberra, Australian Capital Territory, Australia.
Clin Endocrinol (Oxf). 2021 Dec;95(6):863-872. doi: 10.1111/cen.14569. Epub 2021 Aug 16.
Cortisol and dehydroepiandrosterone-sulfate (DHEA-S) are indispensable hormones for normal pregnancy. It is unclear if these hormones, specifically DHEA-S can offer value for predicting poor birth outcome.
To compare prenatal cortisol and DHEA-S levels among pregnant women with normal or poor birth outcome.
Plasma and saliva were collected prospectively from women in second-third trimester of pregnancy. Women with normal birth outcome (NBO) (n = 501) included live birth, no pregnancy complications and ≥2.5 kg infant birth weight. Women with poor birth outcome included adverse birth outcome (ABO) (n = 50) or low birth weight outcome (LBW) (n = 147). Enzyme-linked immunosorbent assay was performed to measure hormone concentrations in plasma and saliva.
Circulatory-DHEA-S levels in pregnant women with ABO were higher than women with NBO (p = .043). Among ABO, only stillbirth cases demonstrated significant increase in circulatory-DHEA-S levels (p = .006). Circulatory and salivary cortisol/DHEA-S ratio was lower among women with stillbirth (p = .004) and ABO outcome (p = .043) respectively compared with women with NBO. Consistently, increased odds of ABO were observed in pregnant women with highest circulatory-DHEA-S levels (odds ratio quartile score 1 vs. 4, 2.79, p = .027) and lowest salivary cortisol/DHEA-S ratio (score 4 vs. 2, 2.83, p = .025). Increased odds of stillbirth outcome were observed in pregnant women with highest circulatory-DHEA-S levels (odds ratio quartile score 1 vs. 4, 8.47, p = .046) and lowest circulatory cortisol/DHEA-S ratio (score 4 vs. 1, 4.803, p = .048). Associations remained significant after adjusting for confounders. Women with LBW did not demonstrate significant changes in cortisol or DHEA-S levels.
Prenatal measurement of DHEA-S or cortisol/DHEA-S ratio may offer significant value for predicting adverse birth, specifically stillbirth outcome.
皮质醇和脱氢表雄酮硫酸酯(DHEA-S)是正常妊娠所必需的激素。目前尚不清楚这些激素,特别是 DHEA-S 是否具有预测不良分娩结局的价值。
比较正常分娩结局和不良分娩结局孕妇的产前皮质醇和 DHEA-S 水平。
前瞻性收集孕妇妊娠中期和晚期的血浆和唾液。正常分娩结局(NBO)(n=501)包括活产、无妊娠并发症和婴儿出生体重≥2.5kg。不良分娩结局包括不良分娩结局(ABO)(n=50)或低出生体重结局(LBW)(n=147)。采用酶联免疫吸附法检测血浆和唾液中激素浓度。
ABO 孕妇的循环 DHEA-S 水平高于 NBO 孕妇(p=0.043)。在 ABO 中,只有死产病例的循环 DHEA-S 水平显著升高(p=0.006)。与 NBO 相比,死产(p=0.004)和 ABO 结局(p=0.043)孕妇的循环和唾液皮质醇/DHEA-S 比值均较低。同样,循环 DHEA-S 水平最高的孕妇发生 ABO 的可能性增加(四分位分数 1 与 4 相比,优势比 quartile score 1 vs. 4, 2.79, p=0.027),唾液皮质醇/DHEA-S 比值最低(分数 4 与 2 相比,2.83, p=0.025)。循环 DHEA-S 水平最高的孕妇(四分位分数 1 与 4 相比,优势比 quartile score 1 vs. 4, 8.47, p=0.046)和循环皮质醇/DHEA-S 比值最低的孕妇(四分位分数 4 与 1 相比,4.803, p=0.048)发生死产结局的可能性增加。调整混杂因素后,相关性仍然显著。LBW 孕妇的皮质醇或 DHEA-S 水平无显著变化。
产前 DHEA-S 或皮质醇/DHEA-S 比值的测定可能对预测不良分娩结局,特别是死产结局具有重要价值。